FDA Issues Urgent Nationwide Recall for a
Recall Announcement The FDA announced a “voluntary recall” of Chantix (varenicline) after testing found “elevated levels of nitrosamines” in certain batches of the smoking-cessation drug. Health Concern Nitrosamines can be harmful at high levels, with long-term exposure linked to cancer. The FDA said the detected amounts were above the “recommended safety threshold,” prompting precautionary action…